CA2348415A1 - Method for gold deposition - Google Patents
Method for gold deposition Download PDFInfo
- Publication number
- CA2348415A1 CA2348415A1 CA002348415A CA2348415A CA2348415A1 CA 2348415 A1 CA2348415 A1 CA 2348415A1 CA 002348415 A CA002348415 A CA 002348415A CA 2348415 A CA2348415 A CA 2348415A CA 2348415 A1 CA2348415 A1 CA 2348415A1
- Authority
- CA
- Canada
- Prior art keywords
- gold
- substrate
- nucleation
- metal
- sites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract 52
- 239000010931 gold Substances 0.000 title claims abstract 43
- 229910052737 gold Inorganic materials 0.000 title claims abstract 43
- 238000000034 method Methods 0.000 title claims abstract 43
- 230000008021 deposition Effects 0.000 title 1
- 230000006911 nucleation Effects 0.000 claims abstract 49
- 239000000758 substrate Substances 0.000 claims abstract 46
- 239000003795 chemical substances by application Substances 0.000 claims abstract 31
- 239000002184 metal Substances 0.000 claims abstract 23
- 229910052751 metal Inorganic materials 0.000 claims abstract 23
- 239000000203 mixture Substances 0.000 claims abstract 20
- 238000010899 nucleation Methods 0.000 claims abstract 20
- 239000012491 analyte Substances 0.000 claims abstract 10
- 238000001514 detection method Methods 0.000 claims abstract 4
- 238000000151 deposition Methods 0.000 claims abstract 3
- 239000000523 sample Substances 0.000 claims 16
- 230000027455 binding Effects 0.000 claims 13
- 239000003153 chemical reaction reagent Substances 0.000 claims 10
- 230000009870 specific binding Effects 0.000 claims 9
- 239000000126 substance Substances 0.000 claims 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 8
- 102000036639 antigens Human genes 0.000 claims 8
- 108091007433 antigens Proteins 0.000 claims 8
- 229920002678 cellulose Polymers 0.000 claims 8
- 239000001913 cellulose Substances 0.000 claims 8
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 239000002923 metal particle Substances 0.000 claims 7
- 108091034117 Oligonucleotide Proteins 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 5
- 108090001008 Avidin Proteins 0.000 claims 4
- 102000014914 Carrier Proteins Human genes 0.000 claims 4
- 229920002101 Chitin Polymers 0.000 claims 4
- 108020004635 Complementary DNA Proteins 0.000 claims 4
- 102000004856 Lectins Human genes 0.000 claims 4
- 108090001090 Lectins Proteins 0.000 claims 4
- 108010090804 Streptavidin Proteins 0.000 claims 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 4
- 239000011230 binding agent Substances 0.000 claims 4
- 108091008324 binding proteins Proteins 0.000 claims 4
- 229960002685 biotin Drugs 0.000 claims 4
- 235000020958 biotin Nutrition 0.000 claims 4
- 239000011616 biotin Substances 0.000 claims 4
- 239000002523 lectin Substances 0.000 claims 4
- 239000003446 ligand Substances 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 238000000926 separation method Methods 0.000 claims 3
- DTMHTVJOHYTUHE-UHFFFAOYSA-N thiocyanogen Chemical compound N#CSSC#N DTMHTVJOHYTUHE-UHFFFAOYSA-N 0.000 claims 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims 2
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 claims 2
- 238000002835 absorbance Methods 0.000 claims 1
- 238000000149 argon plasma sintering Methods 0.000 claims 1
- 238000004630 atomic force microscopy Methods 0.000 claims 1
- 230000005540 biological transmission Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000001493 electron microscopy Methods 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims 1
- 125000004151 quinonyl group Chemical group 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 238000004626 scanning electron microscopy Methods 0.000 claims 1
- 238000007794 visualization technique Methods 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
Abstract
A method for depositing gold on a substrate is provided. By this aspect, nucleation centers are bound, deposited or formed at one or more sites on the substrate, the substrate is then contacted with a treatment composition which comprises soluble gold-providing agent from which gold is deposited onto a nucleation center to yield gold metal deposits. The method of the invention may be used for a variety of image enhancing techniques as well as diagnostic and analyte detection techniques.
Claims (30)
1. A method for depositing gold at one or more sites on a substrate, comprising:
(a) binding, depositing or forming nucleation centers at said one or more sites; said nucleation centers comprising at least one member of a recognition group consisting of two or more {}molecules or complexes which bind {}to each other, the other member including or forming said one or more sites, coupled to at least one nucleation center being one or mere of the group consisting of metal particle, cluster containing metal atoms, a metal-containing complex and molecules.
(b) Contacting under appropriate conditions said one or more sites with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or mare sites.
(a) binding, depositing or forming nucleation centers at said one or more sites; said nucleation centers comprising at least one member of a recognition group consisting of two or more {}molecules or complexes which bind {}to each other, the other member including or forming said one or more sites, coupled to at least one nucleation center being one or mere of the group consisting of metal particle, cluster containing metal atoms, a metal-containing complex and molecules.
(b) Contacting under appropriate conditions said one or more sites with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or mare sites.
2. A method according to Claim 1, wherein the one member of the recognition group is coupled to at last one nucleation center, being one or more of the group consisting of: cluster containing metal atoms and metal containing complexes and metals.
3. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of gold particle, cluster confining gold atoms and gold-containing complexes and molecules.
4. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of cluster containing gold atoms and gold-containing complexes and molecules.
5. A method according to Claim 1, wherein said {} recognition group is a member of the group consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent;
biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
6. A method according to any one of Claims 1 to 5, wherein said treatment composition is an aqueous solution.
7. A method according to Claim 6, wherein said gold-providing agent is Au1(SCN)2.
8. A method according to Claim 7, wherein said reagent is hydroquinone or naphtohydroqninone.
9. A method for assaying presence of a specific substance at sites on a substrate, comprising:
(a) providing conditions showing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising a soluble gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited an the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said sites; and (c) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
(a) providing conditions showing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising a soluble gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited an the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said sites; and (c) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
10. A method according to Claim 9, wherein step (a) comprises:
(a1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said substance, bound to at least one nucleation center being one or more of the group consisting of metal particle, cluster containing metal atoms and a metal-containing complex; and (a2) contacting said substrate with said agents.
(a1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said substance, bound to at least one nucleation center being one or more of the group consisting of metal particle, cluster containing metal atoms and a metal-containing complex; and (a2) contacting said substrate with said agents.
11. A method according to Claim 10, wherein said moiety is included in one member of a recognition couple consisting of two molecules or complexes which specifically bind to one another, the other member included in or constituting said substance.
12. A method according to Claim 11, wherein said recognition couple is a member of the group consisting of an antigen and as antibody or an antibody derivative with as antigen binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; said moiety being one of the recognition couple and said substance being or including the other.
13. A method according to any one of Claims 9-12, for assaying the presence of one or more target oligonucleotides with a specific target sequence in a sample, comprising:
(a) providing a substrate carrying one or more probe oligonucleotides each with a probing sequence complementary to one of said target sequences;
(b) contacting said substrate with the sample and providing conditions allowing formation of nucleation centers where a target oligonucleotide hybridizes to a probe oligonucleotide;
(c) contacting said substrate with a treatment composition comprising a gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to forth gold metal deposits at said sites; and (d) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating the presence of said substance at said site.
(a) providing a substrate carrying one or more probe oligonucleotides each with a probing sequence complementary to one of said target sequences;
(b) contacting said substrate with the sample and providing conditions allowing formation of nucleation centers where a target oligonucleotide hybridizes to a probe oligonucleotide;
(c) contacting said substrate with a treatment composition comprising a gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to forth gold metal deposits at said sites; and (d) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating the presence of said substance at said site.
14. A method according co Claim 13, wherein said step (b) comprises:
(b1) treating said sample to bind a label to oligonucleotides in the sample;
(b2) contacting said sample with said substrate; and (b3) contacting said substrate with a nucleation center-containing agent, capable of specific binding to said label.
(b1) treating said sample to bind a label to oligonucleotides in the sample;
(b2) contacting said sample with said substrate; and (b3) contacting said substrate with a nucleation center-containing agent, capable of specific binding to said label.
15. A method according to Claim 13, wherein said step (b) comprises:
(b1) treating sand sample so as to bind nucleation centers to oligonucleotides present therein, and (b2) contacting said samples with said substrate.
(b1) treating sand sample so as to bind nucleation centers to oligonucleotides present therein, and (b2) contacting said samples with said substrate.
16. A method according to any one of Claims 9 to 15, wherein said nucleation center is a gold particle a cluster containing gold atoms, or a gold-containing complex or molecules.
17. A method according to any one of Claims 9 to 16, wherein said treatment composition is an aqueous solution.
18. A method according so Claim 17, wherein said gold-providing agent is Au1(SCN)2 and said reagent is a quinone.
19. A method according to any one of Claims 9 to 18, wherein said substrate is a specimen for viewing in an imaging or visualization technique.
20. A method according to Claim 19, wherein the detention technique is based on light.
21. A method according to Claim 19, wherein the {} detection technique is based on light absorbance and/or light transmission and/or light reflectance and/or light scattering.
22. A method according to Claim 19, wherein said detection is made by techniques selected from: tansmission electron microscopy, scanning electron microscopy, atomic force microscopy.
23. A method according to Claim 19, for preparing the specimen for viewing in a microscope, comprising the following steps:
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at selective sites.
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at selective sites.
24. A method according to any one of Claims 9 to 18, wherein said substrate contains separated fractions of a sample.
25. A method according to Claim 23 for identifying locations of a specific separation product on the substrate, comprising the steps of:
(a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate to a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center; and (b) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
25. A method for assaying presence of an analyte in a sample comprising:
(a) providing a substrate carrying capturing agents which bind said analyze;
(b) contacting said substrate with said sample, whereby said analyte binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyze;
(d) contacting said substrate with a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
(a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate to a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center; and (b) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
25. A method for assaying presence of an analyte in a sample comprising:
(a) providing a substrate carrying capturing agents which bind said analyze;
(b) contacting said substrate with said sample, whereby said analyte binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyze;
(d) contacting said substrate with a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
26. A method according to Claire 25, wherein step (c) comprises;
(c1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyze, coupled to at least one nucleation center being one or more of the group consisting of metal particle, cluster of metal atoms and a metal-containing complex; and (c2) contacting said substrate with said agents.
(c1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyze, coupled to at least one nucleation center being one or more of the group consisting of metal particle, cluster of metal atoms and a metal-containing complex; and (c2) contacting said substrate with said agents.
27. A method according to Claim 26, wherein said analyze is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; and said at least one moiety is the other of said binding couple.
28. A method according to Claim 25 wherein step (b) comprises:
(b1) contacting said sample with nucleation centers, the nucleation centers being one or more of the group consisting of metal particles, cluster of metal atoms and metal-containing complexes or molecules, and providing conditions for coupling of said nucleation centers to the analyte if present in the sample, thus obtaining a modified sample containing modified analytes;
and (b2) contacting said substrate with said modified analytes bound to said nucleation centers.
(b1) contacting said sample with nucleation centers, the nucleation centers being one or more of the group consisting of metal particles, cluster of metal atoms and metal-containing complexes or molecules, and providing conditions for coupling of said nucleation centers to the analyte if present in the sample, thus obtaining a modified sample containing modified analytes;
and (b2) contacting said substrate with said modified analytes bound to said nucleation centers.
29. A method according to Claim 28, wherein said analyte is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin;
cellulose or chitin and cellulose binding domain; and said capturing agent is the other of said binding couple.
cellulose or chitin and cellulose binding domain; and said capturing agent is the other of said binding couple.
30. A method according to any one of Claims 25 to 29, wherein said capturing agents are carried on the substrate between electrodes such that gold deposited onto said nucleation enters in step (d) establishes an electric contact between the electrodes; and detection of the gold deposits in step (c) is performed by measuring current-potential relationship between the electrodes.
30. A method according to any one of Claims 25 to 30, wherein said at least one metal particle, cluster of metal atoms or a metal-containing complex is a gold particle or cluster containing gold atoms.
32. A method according to any one of Claims 25 to 31, wherein said treatment composition is an aqueous solution.
33. A method according to Claim 32, wherein said gold providing agent is Au1(SCN)2.
34. A method according to Claim 32, wherein said reagent is a hydroquinone.
35. A kit for use in the method according to any one of Claims 1 to 34 36. A kit according to Claim 35, comprising a treatment composition which comprises a soluble gold-providing agent, being a gold-containing molecule or complex and comprises a reagent, the composition being kinetically stable such that upon contact with a substrate gold is deposited on a substrate essentially only at sifts of the substrate containing nucleation centers.
37. A kit according to Claim 35 or 35, further comprising nucleation center-forming agents, for forming nucleation centers at one or more sites on the substrate, said agents comprise each at least one {} member of a recognition group having a specific binding affinity to a substance present at said one or more sites coupled to at least one nucleation center moiety, being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex or molecule.
38. A kit for use in a method according to any one of Claims 25 to 34, for assaying an analyte in a sample, comprising:
(i) a substrate carrying capturing agents which bind said analyte;
(ii) agents for forming nucleation centers at portions of the substrate on which said analyte becomes immobilized;
(iii) a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers.
39. A kit according to Claim 3$, wherein said agent for forming nucleation centers comprises a nucleation center and substances needed in order to couple said nucleation center to said analyze.
40. A kit according to Claim 38, further comprising nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyte, coupled to at least one nucleation center moiety being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex.
41. A kit according to any one of Claims 38 to 40, wherein said substrate comprises two or more electrodes, and said capturing agents are carried within gaps between the electrodes.
30. A method according to any one of Claims 25 to 30, wherein said at least one metal particle, cluster of metal atoms or a metal-containing complex is a gold particle or cluster containing gold atoms.
32. A method according to any one of Claims 25 to 31, wherein said treatment composition is an aqueous solution.
33. A method according to Claim 32, wherein said gold providing agent is Au1(SCN)2.
34. A method according to Claim 32, wherein said reagent is a hydroquinone.
35. A kit for use in the method according to any one of Claims 1 to 34 36. A kit according to Claim 35, comprising a treatment composition which comprises a soluble gold-providing agent, being a gold-containing molecule or complex and comprises a reagent, the composition being kinetically stable such that upon contact with a substrate gold is deposited on a substrate essentially only at sifts of the substrate containing nucleation centers.
37. A kit according to Claim 35 or 35, further comprising nucleation center-forming agents, for forming nucleation centers at one or more sites on the substrate, said agents comprise each at least one {} member of a recognition group having a specific binding affinity to a substance present at said one or more sites coupled to at least one nucleation center moiety, being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex or molecule.
38. A kit for use in a method according to any one of Claims 25 to 34, for assaying an analyte in a sample, comprising:
(i) a substrate carrying capturing agents which bind said analyte;
(ii) agents for forming nucleation centers at portions of the substrate on which said analyte becomes immobilized;
(iii) a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers.
39. A kit according to Claim 3$, wherein said agent for forming nucleation centers comprises a nucleation center and substances needed in order to couple said nucleation center to said analyze.
40. A kit according to Claim 38, further comprising nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyte, coupled to at least one nucleation center moiety being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex.
41. A kit according to any one of Claims 38 to 40, wherein said substrate comprises two or more electrodes, and said capturing agents are carried within gaps between the electrodes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12677698A IL126776A (en) | 1998-10-27 | 1998-10-27 | Method for gold depositions |
IL126776 | 1998-10-27 | ||
PCT/IL1999/000570 WO2000025136A1 (en) | 1998-10-27 | 1999-10-27 | Method for gold deposition |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2348415A1 true CA2348415A1 (en) | 2000-05-04 |
CA2348415C CA2348415C (en) | 2010-09-07 |
Family
ID=11072075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2348415A Expired - Fee Related CA2348415C (en) | 1998-10-27 | 1999-10-27 | Method for gold deposition |
Country Status (12)
Country | Link |
---|---|
US (2) | US7056748B1 (en) |
EP (1) | EP1125128B1 (en) |
JP (1) | JP4453856B2 (en) |
CN (1) | CN1145028C (en) |
AT (1) | ATE320002T1 (en) |
AU (1) | AU759205B2 (en) |
CA (1) | CA2348415C (en) |
DE (1) | DE69930285T2 (en) |
ES (1) | ES2263289T3 (en) |
IL (1) | IL126776A (en) |
RU (1) | RU2242005C2 (en) |
WO (1) | WO2000025136A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6984491B2 (en) | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
EP1818417B1 (en) | 1996-07-29 | 2014-02-12 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US7098320B1 (en) | 1996-07-29 | 2006-08-29 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6767702B2 (en) | 1996-07-29 | 2004-07-27 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
US6750016B2 (en) | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
IL121312A (en) | 1997-07-14 | 2001-09-13 | Technion Res & Dev Foundation | Microelectronic components, their fabrication and electronic networks comprising them |
US6974669B2 (en) | 2000-03-28 | 2005-12-13 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified nanoparticles |
IL124322A (en) * | 1998-05-04 | 2002-05-23 | Technion Res & Dev Foundation | Detection of an entity in a sample |
IL126776A (en) | 1998-10-27 | 2001-04-30 | Technion Res & Dev Foundation | Method for gold depositions |
EP1196629A2 (en) | 1999-04-07 | 2002-04-17 | Dennis Michael Connolly | High resolution dna detection methods and devices |
US7364920B2 (en) | 1999-10-27 | 2008-04-29 | Technion Research And Development Foundation Ltd. | Method for gold deposition |
US6726847B2 (en) | 2000-12-06 | 2004-04-27 | Northwestern University | Silver stain removal by chemical etching and sonication |
CA2466656C (en) | 2001-11-09 | 2013-07-02 | Nanosphere, Inc. | Bioconjugate-nanoparticle probes |
EP1439392A3 (en) * | 2003-01-15 | 2005-07-27 | Agilent Technologies, Inc. | Biosensor systems and methods for determining the presence of biomolecules |
DE10322912A1 (en) * | 2003-05-21 | 2004-12-16 | Bayer Technology Services Gmbh | Methods for the detection of nucleic acids |
DE10328136A1 (en) * | 2003-06-23 | 2005-01-27 | Infineon Technologies Ag | Sensor element, sensor array and method for detecting particles possibly contained in an analyte |
DE10330717A1 (en) * | 2003-07-03 | 2005-02-10 | Friedrich-Schiller-Universität Jena | Apparatus and method for detection of analyte |
GB0812679D0 (en) | 2008-07-10 | 2008-08-20 | Sec Dep For Innovation Universities | Sample carrier for effecting chemical assays |
AU2008328588B2 (en) | 2007-11-26 | 2013-09-05 | Agplus Diagnostics Limited | Electrochemical detection of a metal - labelled analyte |
ITTO20080632A1 (en) * | 2008-08-12 | 2010-02-13 | Consiglio Naz Delle Ricerche Infm Istituto | PROCEDURE FOR MICROMETRIC AND NANOMETRIC SCALE CONFIGURATION OF METALLIC LAYERS ON A SUBSTRATE |
GB201217390D0 (en) | 2012-09-28 | 2012-11-14 | Agplus Diagnostics Ltd | Test device and sample carrier |
RU2578977C1 (en) * | 2015-05-12 | 2016-03-27 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт глазных болезней" | Method of preparing biological sample for analysis by scanning electron microscopy |
CN115951070A (en) * | 2023-01-19 | 2023-04-11 | 北京青莲百奥生物科技有限公司 | Method for detecting protein in sample |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3032436A (en) * | 1960-11-18 | 1962-05-01 | Metal Proc Co Inc | Method and composition for plating by chemical reduction |
GB1343642A (en) * | 1971-04-28 | 1974-01-16 | May & Baker Ltd | Zinc sulphided pigments |
US3833894A (en) | 1973-06-20 | 1974-09-03 | Ibm | Organic memory device |
US4314821A (en) | 1979-04-09 | 1982-02-09 | Minnesota Mining And Manufacturing Company | Sandwich immunoassay using piezoelectric oscillator |
US4323641A (en) * | 1980-08-15 | 1982-04-06 | The United States Of America As Represented By The Secretary Of The Navy | Photographic image enhancement by a gold-toning neutron-activation process |
US5241060A (en) * | 1982-06-23 | 1993-08-31 | Enzo Diagnostics, Inc. | Base moiety-labeled detectable nucleatide |
GB8331514D0 (en) * | 1983-11-25 | 1984-01-04 | Janssen Pharmaceutica Nv | Visualization method |
US5202151A (en) * | 1985-10-14 | 1993-04-13 | Hitachi, Ltd. | Electroless gold plating solution, method of plating with gold by using the same, and electronic device plated with gold by using the same |
US4822566A (en) | 1985-11-19 | 1989-04-18 | The Johns Hopkins University | Optimized capacitive sensor for chemical analysis and measurement |
US4794089A (en) | 1986-03-25 | 1988-12-27 | Midwest Research Microscopy, Inc. | Method for electronic detection of a binding reaction |
US5137827A (en) * | 1986-03-25 | 1992-08-11 | Midwest Research Technologies, Inc. | Diagnostic element for electrical detection of a binding reaction |
US5491098A (en) * | 1987-03-09 | 1996-02-13 | Janssen Pharmaceutica N.V. | Method for depositing metal particles on a marker |
US5283174A (en) * | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
GB8800702D0 (en) * | 1988-01-13 | 1988-02-10 | Nycomed As | Test method & reagent kit therefor |
US5063417A (en) | 1988-07-18 | 1991-11-05 | California Institute Of Technology | Molecular shift register based on electron transfer |
US5108889A (en) | 1988-10-12 | 1992-04-28 | Thorne, Smith, Astill Technologies, Inc. | Assay for determining analyte using mercury release followed by detection via interaction with aluminum |
AU4647589A (en) | 1988-11-10 | 1990-05-28 | Midwest Research Technologies, Inc. | Method for electrical detection of a binding reaction |
US5089545A (en) | 1989-02-12 | 1992-02-18 | Biotech International, Inc. | Switching and memory elements from polyamino acids and the method of their assembly |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
DE3924454A1 (en) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS) |
CA2026409C (en) | 1989-09-29 | 2004-11-09 | Ernest G. Schutt | Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof |
CA2034266A1 (en) | 1990-02-27 | 1991-08-28 | Paul A. D'orazio | Thick film reagent spreading and reagent immobilization layer |
HU218095B (en) | 1990-05-01 | 2000-05-28 | Amgen Inc. | Process for reducing transitional contaminations in amplification processes |
US5714327A (en) * | 1990-07-19 | 1998-02-03 | Kreatech Diagnostics | Platinum-containing compounds, methods for their preparation and applications thereof |
US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
JP3064001B2 (en) | 1990-10-09 | 2000-07-12 | 株式会社アドバンス | Molecular fixation device |
US5294369A (en) | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
EP0495253B1 (en) * | 1991-01-15 | 1995-05-10 | Agfa-Gevaert N.V. | Method for the photographic production of silver images |
JP2778304B2 (en) | 1991-09-17 | 1998-07-23 | 三菱電機株式会社 | Organic electronic device materials |
JPH05105444A (en) * | 1991-09-25 | 1993-04-27 | Mitsubishi Materials Corp | Manufacture of spheroidal gold fine grain |
US6051380A (en) | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
US5787032A (en) | 1991-11-07 | 1998-07-28 | Nanogen | Deoxyribonucleic acid(DNA) optical storage using non-radiative energy transfer between a donor group, an acceptor group and a quencher group |
IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
GB9210176D0 (en) * | 1992-05-12 | 1992-06-24 | Cemu Bioteknik Ab | Chemical method |
JP3637056B2 (en) | 1992-06-01 | 2005-04-06 | エール ユニバシティ | Integrated circuit structure and method of manufacturing integrated circuit structure |
US5331183A (en) | 1992-08-17 | 1994-07-19 | The Regents Of The University Of California | Conjugated polymer - acceptor heterojunctions; diodes, photodiodes, and photovoltaic cells |
US5312527A (en) | 1992-10-06 | 1994-05-17 | Concordia University | Voltammetric sequence-selective sensor for target polynucleotide sequences |
CN1122138A (en) | 1993-01-21 | 1996-05-08 | 海布里顿公司 | Foldback triplex-forming oligonucleotides |
US5384265A (en) * | 1993-03-26 | 1995-01-24 | Geo-Centers, Inc. | Biomolecules bound to catalytic inorganic particles, immunoassays using the same |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US5837546A (en) | 1993-08-24 | 1998-11-17 | Metrika, Inc. | Electronic assay device and method |
US6071699A (en) | 1996-06-07 | 2000-06-06 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5824473A (en) | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
US5563424A (en) | 1994-03-24 | 1996-10-08 | Uniax Corporation | Polymer grid triodes |
US5871918A (en) * | 1996-06-20 | 1999-02-16 | The University Of North Carolina At Chapel Hill | Electrochemical detection of nucleic acid hybridization |
WO1996028538A1 (en) * | 1995-03-10 | 1996-09-19 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
US5679519A (en) * | 1995-05-09 | 1997-10-21 | Oprandy; John J. | Multi-label complex for enhanced sensitivity in electrochemiluminescence assay |
US5614832A (en) * | 1995-06-02 | 1997-03-25 | International Business Machines Corporation | High voltage protected ohmmeter |
US5595878A (en) * | 1995-06-02 | 1997-01-21 | Boron Biologicals, Inc. | Detection of biopolymers and biooligomers with boron hydride labels |
JPH0973780A (en) | 1995-09-01 | 1997-03-18 | Toshiba Corp | Semiconductor integrated circuit |
US5888370A (en) * | 1996-02-23 | 1999-03-30 | Board Of Regents, The University Of Texas System | Method and apparatus for fractionation using generalized dielectrophoresis and field flow fractionation |
CA2255952A1 (en) | 1996-05-22 | 1997-11-27 | Australian Membrane And Biotechnology Research Institute | Nucleic acid sensor |
DE19622628A1 (en) | 1996-06-05 | 1997-12-11 | Boehringer Mannheim Gmbh | Stabilization of metal conjugates |
US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6750016B2 (en) | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6984491B2 (en) | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
JPH1068730A (en) | 1996-08-27 | 1998-03-10 | Wako Pure Chem Ind Ltd | Test tool for immunochromatography |
US5787332A (en) | 1996-09-26 | 1998-07-28 | Fansteel Inc. | Process for recovering tantalum and/or niobium compounds from composites containing a variety of metal compounds |
US5874046A (en) | 1996-10-30 | 1999-02-23 | Raytheon Company | Biological warfare agent sensor system employing ruthenium-terminated oligonucleotides complementary to target live agent DNA sequences |
US6306584B1 (en) | 1997-01-21 | 2001-10-23 | President And Fellows Of Harvard College | Electronic-property probing of biological molecules at surfaces |
AU748939B2 (en) | 1997-02-20 | 2002-06-13 | Regents Of The University Of California, The | Plasmon resonant particles, methods and apparatus |
US5946550A (en) | 1997-03-14 | 1999-08-31 | University Of Connecticut | Self-assembled semiconductor and method of making same |
US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
US6210880B1 (en) | 1997-09-19 | 2001-04-03 | Third Wave Technologies, Inc. | Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides |
WO1998053841A1 (en) | 1997-05-27 | 1998-12-03 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters |
IL121312A (en) * | 1997-07-14 | 2001-09-13 | Technion Res & Dev Foundation | Microelectronic components, their fabrication and electronic networks comprising them |
US20020025552A1 (en) | 1998-01-06 | 2002-02-28 | Institut Pasteur | Screening interactor molecules with whole genome oligonucleotide or polynucleotide arrays |
WO1999036573A1 (en) | 1998-01-20 | 1999-07-22 | Schichman Steven A | Detection of genetic information |
US6060023A (en) | 1998-03-31 | 2000-05-09 | Motorola, Inc. | Molecular sensing apparatus |
IL124322A (en) | 1998-05-04 | 2002-05-23 | Technion Res & Dev Foundation | Detection of an entity in a sample |
WO1999060165A1 (en) | 1998-05-20 | 1999-11-25 | Dennis Michael Connolly | Chemically assembled nano-scale devices |
US6093370A (en) | 1998-06-11 | 2000-07-25 | Hitachi, Ltd. | Polynucleotide separation method and apparatus therefor |
US6171870B1 (en) * | 1998-08-06 | 2001-01-09 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
IL126776A (en) | 1998-10-27 | 2001-04-30 | Technion Res & Dev Foundation | Method for gold depositions |
US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
EP1196629A2 (en) | 1999-04-07 | 2002-04-17 | Dennis Michael Connolly | High resolution dna detection methods and devices |
US7364920B2 (en) * | 1999-10-27 | 2008-04-29 | Technion Research And Development Foundation Ltd. | Method for gold deposition |
EP1360318B1 (en) * | 2000-07-11 | 2006-04-26 | Northwestern University | Method of detection by enhancement of silver staining |
US6670113B2 (en) * | 2001-03-30 | 2003-12-30 | Nanoprobes | Enzymatic deposition and alteration of metals |
US7266855B2 (en) * | 2002-06-04 | 2007-09-11 | Qingping Zhuan | Electric toothbrush |
US7488607B2 (en) * | 2003-09-30 | 2009-02-10 | Agilent Technologies, Inc. | Electronically readable microarray with electronic addressing function |
US20060014083A1 (en) * | 2004-03-01 | 2006-01-19 | University Of Washington | Methods and systems for fabricating electronic and/or microfluidic structures on elastomeric substrates |
-
1998
- 1998-10-27 IL IL12677698A patent/IL126776A/en not_active IP Right Cessation
-
1999
- 1999-10-27 CN CNB998148814A patent/CN1145028C/en not_active Expired - Fee Related
- 1999-10-27 WO PCT/IL1999/000570 patent/WO2000025136A1/en active IP Right Grant
- 1999-10-27 DE DE69930285T patent/DE69930285T2/en not_active Expired - Lifetime
- 1999-10-27 EP EP99952775A patent/EP1125128B1/en not_active Expired - Lifetime
- 1999-10-27 ES ES99952775T patent/ES2263289T3/en not_active Expired - Lifetime
- 1999-10-27 CA CA2348415A patent/CA2348415C/en not_active Expired - Fee Related
- 1999-10-27 US US09/830,457 patent/US7056748B1/en not_active Expired - Lifetime
- 1999-10-27 JP JP2000578659A patent/JP4453856B2/en not_active Expired - Fee Related
- 1999-10-27 AU AU64859/99A patent/AU759205B2/en not_active Ceased
- 1999-10-27 AT AT99952775T patent/ATE320002T1/en not_active IP Right Cessation
- 1999-10-27 RU RU2001114202/15A patent/RU2242005C2/en not_active IP Right Cessation
-
2003
- 2003-08-11 US US10/638,503 patent/US7851149B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU759205B2 (en) | 2003-04-10 |
US20040033626A1 (en) | 2004-02-19 |
RU2242005C2 (en) | 2004-12-10 |
EP1125128B1 (en) | 2006-03-08 |
ES2263289T3 (en) | 2006-12-01 |
WO2000025136A1 (en) | 2000-05-04 |
EP1125128A1 (en) | 2001-08-22 |
JP2002528098A (en) | 2002-09-03 |
CA2348415C (en) | 2010-09-07 |
CN1145028C (en) | 2004-04-07 |
IL126776A0 (en) | 1999-08-17 |
IL126776A (en) | 2001-04-30 |
CN1331800A (en) | 2002-01-16 |
US7056748B1 (en) | 2006-06-06 |
AU6485999A (en) | 2000-05-15 |
ATE320002T1 (en) | 2006-03-15 |
DE69930285T2 (en) | 2006-12-07 |
DE69930285D1 (en) | 2006-05-04 |
US7851149B2 (en) | 2010-12-14 |
JP4453856B2 (en) | 2010-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2348415A1 (en) | Method for gold deposition | |
RU2001114202A (en) | The method of deposition of gold, the method for determining the presence of a particular substance on active centers on a substrate, the method for determining the presence of an analyte in a sample and the set of tools used in the method (options) | |
EP2644615B1 (en) | SERS nanotag assays | |
JP2002528098A5 (en) | ||
US6025202A (en) | Self-assembled metal colloid monolayers and detection methods therewith | |
US6242264B1 (en) | Self-assembled metal colloid monolayers having size and density gradients | |
US7727776B2 (en) | Core-shell nanoparticles for detection based on SERS | |
JPH09509056A (en) | Highly specific surfaces for biological reactions, methods of making them, and methods of their use | |
WO2003095973A2 (en) | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection | |
Wang et al. | Multiplexed gold nanorod array biochip for multi-sample analysis | |
Baschong et al. | Preparation, use, and enlargement of ultrasmall gold particles in immunoelectron microscopy | |
WO2009070742A2 (en) | Methods and compositions for signal enhancement using multivalent interactions | |
EP2132555B1 (en) | Method for fabrication of photonic biosensor arrays | |
JP3214795B2 (en) | Biotin silane compounds and binding matrices containing these compounds | |
US20030087277A1 (en) | Means and methods for detection of binding of members of specific binding pairs | |
US7364920B2 (en) | Method for gold deposition | |
JPH06504917A (en) | Analytical methods and equipment | |
Schüler et al. | Enzyme-induced growth of silver nanoparticles studied on single particle level | |
WO2008082710A2 (en) | A method of surface plasmon resonance (spr) technology to detect genomic aberrations in patients with multiple myeloma | |
DE10128093A1 (en) | Specific-binding method for detecting substances, useful in sandwich immunoassays, based on binding of colloidal particle to a surface through nucleic acid hybridization | |
JP4637565B2 (en) | Biological sample labeling and biological substance labeling method and biological substance inspection method | |
MXPA01004280A (en) | Method for gold deposition | |
Berlina et al. | Application of aminophenylboronic acid conjugated with protein carrier for aptachromatographic detection of lead ions | |
WO2008066982A2 (en) | A method of surface plasmon resonance (spr) technology to detect genomic aberrations in patients with chronic lymphocytic leukemia | |
WO2005003772A1 (en) | Device and method for identifying an analyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20181029 |